Efficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous Malformations
Clinical trial NCT06264531 · RECRUITING
Trial details
- NCT number
- NCT06264531
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-16
- Primary completion
- 2028-01-15
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.